kidney cancer (Cancer)
Information
- Disease name
- kidney cancer
- Disease ID
- DOID:263
- Description
- "A urinary system cancer that is located_in the kidney." [url:http\://en.wikipedia.org/wiki/Kidney_cancer]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03308396 | Active, not recruiting | Phase 1/Phase 2 | Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer | December 19, 2017 | December 2023 |
| NCT03345563 | Active, not recruiting | N/A | Project HERO: Health Empowerment & Recovery Outcomes | July 19, 2019 | December 31, 2030 |
| NCT04337970 | Active, not recruiting | Phase 1/Phase 2 | Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer | April 6, 2020 | October 2024 |
| NCT03634540 | Active, not recruiting | Phase 2 | A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) | September 27, 2018 | August 31, 2025 |
| NCT04922307 | Active, not recruiting | N/A | Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer | July 23, 2021 | June 15, 2027 |
| NCT03455452 | Active, not recruiting | Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer | January 21, 2018 | March 31, 2025 | |
| NCT04508725 | Active, not recruiting | N/A | Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) | December 5, 2020 | December 2024 |
| NCT04383210 | Active, not recruiting | Phase 2 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | September 29, 2020 | March 2025 |
| NCT02950766 | Active, not recruiting | Phase 1 | NeoVax Plus Ipilimumab in Renal Cell Carcinoma | March 3, 2019 | September 30, 2026 |
| NCT02974738 | Active, not recruiting | Phase 1 | A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) | December 7, 2016 | April 14, 2025 |
| NCT02293980 | Active, not recruiting | Phase 1 | A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) | November 25, 2014 | November 30, 2026 |
| NCT01217931 | Active, not recruiting | Phase 2 | Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial | January 19, 2011 | January 31, 2025 |
| NCT03354390 | Active, not recruiting | Phase 1 | HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma | July 20, 2018 | December 31, 2032 |
| NCT01120249 | Active, not recruiting | Phase 3 | S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery | April 1, 2011 | October 15, 2026 |
| NCT00600496 | Active, not recruiting | Phase 1 | A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | December 14, 2007 | December 31, 2024 |
| NCT02964078 | Active, not recruiting | Phase 2 | Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer | April 25, 2017 | June 2024 |
| NCT00579514 | Active, not recruiting | N/A | Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients | March 2000 | March 2025 |
| NCT04000880 | Active, not recruiting | N/A | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health | March 4, 2020 | August 31, 2024 |
| NCT05941637 | Available | An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF) | |||
| NCT00003542 | Completed | Phase 1/Phase 2 | Interferon Alfa in Treating Patients With Advanced Kidney Cancer | May 1998 | April 2004 |
| NCT00003551 | Completed | Phase 2 | Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer | August 1998 | September 2004 |
| NCT00003553 | Completed | Phase 2 | Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer | February 9, 1998 | June 27, 2011 |
| NCT00003584 | Completed | Phase 2 | Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer | July 1998 | December 2000 |
| NCT00003585 | Completed | Phase 1/Phase 2 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | August 1996 | August 2002 |
| NCT00003656 | Completed | Phase 2 | Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer | January 1999 | May 2008 |
| NCT00003657 | Completed | Phase 2 | High-dose ICE With Amifostine | July 1998 | June 2002 |
| NCT00003683 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer | March 1998 | April 2002 |
| NCT00003887 | Completed | Phase 2 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | August 1998 | February 2003 |
| NCT00003914 | Completed | Phase 2 | Dolastatin 10 in Treating Patients With Advanced Kidney Cancer | August 1999 | May 2009 |
| NCT00003928 | Completed | Phase 2 | Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer | January 1999 | April 2006 |
| NCT00003968 | Completed | Phase 2 | Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer | June 1999 | |
| NCT00004065 | Completed | Phase 1 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | July 1999 | March 2005 |
| NCT00004095 | Completed | Phase 1 | Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | August 1999 | October 2008 |
| NCT00004135 | Completed | Phase 2 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | February 1999 | August 2007 |
| NCT00004157 | Completed | Phase 2 | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | August 2000 | April 2002 |
| NCT00004244 | Completed | Phase 1 | Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | March 2000 | September 2008 |
| NCT00004879 | Completed | Phase 1 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | April 2000 | |
| NCT00004880 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Advanced Kidney Cancer | June 1997 | |
| NCT00004890 | Completed | Phase 1 | Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer | December 2000 | December 2002 |
| NCT00005027 | Completed | Phase 2 | Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer | June 2000 | March 2005 |
| NCT00005045 | Completed | Phase 2 | Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer | March 2000 | June 2004 |
| NCT00005056 | Completed | Phase 2 | Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | March 1999 | July 2006 |
| NCT00005069 | Completed | Phase 2 | Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer | January 2000 | July 2001 |
| NCT00005816 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer | February 2000 | August 2002 |
| NCT00005952 | Completed | Phase 1/Phase 2 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | August 2000 | November 2005 |
| NCT00005966 | Completed | Phase 3 | Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer | October 2000 | |
| NCT00005995 | Completed | Phase 3 | AE-941 in Treating Patients With Metastatic Kidney Cancer | October 2000 | |
| NCT00006022 | Completed | Phase 1 | Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer | September 2000 | January 2004 |
| NCT00006255 | Completed | Phase 2 | Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases | April 2000 | March 2005 |
| NCT00006384 | Completed | Phase 2 | SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer | November 2000 | February 2007 |
| NCT00006483 | Completed | Phase 2 | Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung | October 2000 | January 2013 |
| NCT00006864 | Completed | Phase 4 | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | July 2000 | July 2007 |
| NCT00006968 | Completed | Phase 1/Phase 2 | Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer | September 2000 | |
| NCT00010283 | Completed | Phase 1/Phase 2 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | July 2000 | July 2002 |
| NCT00011973 | Completed | Phase 2 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | December 2000 | October 2005 |
| NCT00012337 | Completed | Phase 2 | ZD 1839 in Treating Patients With Metastatic Kidney Cancer | January 2001 | March 2004 |
| NCT00014183 | Completed | Phase 2 | ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer | January 2001 | August 2005 |
| NCT00016237 | Completed | Phase 1 | Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment | December 2000 | |
| NCT00016939 | Completed | Phase 2 | Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | May 2001 | April 2006 |
| NCT00017329 | Completed | Phase 2 | PS-341 in Treating Patients With Metastatic Kidney Cancer | April 2001 | |
| NCT00018941 | Completed | Phase 3 | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | April 1991 | May 2003 |
| NCT00019019 | Completed | Phase 1 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | October 1994 | July 2006 |
| NCT00019955 | Completed | Phase 2 | Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) | March 2000 | |
| NCT00020150 | Completed | Phase 1 | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors | June 2000 | |
| NCT00020527 | Completed | N/A | Caspofungin Acetate in Treating Children With Fever and Neutropenia | March 2001 | June 2003 |
| NCT00020540 | Completed | Phase 1 | Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | March 2001 | |
| NCT00021021 | Completed | Phase 2 | RPI.4610 in Treating Patients With Metastatic Kidney Cancer | September 2001 | February 2004 |
| NCT00024258 | Completed | Phase 2 | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors | March 2001 | May 2009 |
| NCT00025376 | Completed | Phase 2 | PS-341 in Treating Patients With Metastatic Kidney Cancer | October 2001 | March 2006 |
| NCT00027573 | Completed | Phase 2 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer | October 2001 | June 2006 |
| NCT00030108 | Completed | Phase 1 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | November 2001 | April 2010 |
| NCT00030342 | Completed | Phase 1/Phase 2 | Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer | November 2001 | January 2008 |
| NCT00053820 | Completed | Phase 3 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | July 2002 | December 2006 |
| NCT00002466 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer | May 1990 | May 2005 |
| NCT00002473 | Completed | Phase 3 | Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer | March 1992 | |
| NCT00002475 | Completed | Phase 2 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | April 1991 | June 2009 |
| NCT00002515 | Completed | Phase 2 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | October 1992 | April 2005 |
| NCT00002610 | Completed | Phase 3 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | January 1996 | February 2006 |
| NCT00002611 | Completed | Phase 3 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | July 1995 | August 2003 |
| NCT00002641 | Completed | Phase 3 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | February 1995 | June 2012 |
| NCT00002733 | Completed | Phase 2 | Biological Therapy in Treating Patients With Metastatic Cancer | January 1996 | January 2000 |
| NCT00002737 | Completed | Phase 3 | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | March 1996 | |
| NCT00002764 | Completed | Phase 3 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | April 1996 | |
| NCT00003091 | Completed | Phase 2 | High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | January 1996 | January 2000 |
| NCT00003102 | Completed | Phase 1/Phase 2 | Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer | November 17, 1998 | May 27, 2003 |
| NCT00003103 | Completed | Phase 1/Phase 2 | Chemotherapy in Treating Patients With Solid Tumors | August 1997 | August 2002 |
| NCT00003107 | Completed | Phase 1 | Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors | October 1997 | |
| NCT00003126 | Completed | Phase 3 | Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer | June 1997 | August 2002 |
| NCT00003308 | Completed | Phase 2 | Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma | February 2, 1999 | |
| NCT00003390 | Completed | Phase 2 | 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer | June 1998 | August 2004 |
| NCT00003408 | Completed | Phase 2 | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer | April 1998 | March 2000 |
| NCT00036959 | Completed | Phase 1 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | March 2002 | February 2010 |
| NCT00039052 | Completed | Phase 1 | Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer | January 2002 | July 2008 |
| NCT00039429 | Completed | Phase 2 | Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer | July 14, 2003 | |
| NCT00042965 | Completed | Phase 2 | Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer | October 2002 | September 2006 |
| NCT00045279 | Completed | Phase 2 | PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer | April 2002 | September 2005 |
| NCT00045370 | Completed | Phase 1 | Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | April 2002 | November 2003 |
| NCT00045487 | Completed | Phase 2 | Erlotinib in Treating Patients With Advanced Kidney Cancer | June 2002 | May 2008 |
| NCT00053807 | Completed | Phase 3 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | February 1998 | |
| NCT00056095 | Completed | Phase 2 | Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer | November 4, 2002 | August 17, 2016 |
| NCT00057889 | Completed | Phase 2 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer | February 2003 | February 2008 |
| NCT00058318 | Completed | Phase 2 | S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer | December 2004 | November 2008 |
| NCT00066599 | Completed | Phase 2 | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | June 2003 | June 2004 |
| NCT00072046 | Completed | Phase 3 | Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) | October 2003 | November 2012 |
| NCT00073879 | Completed | N/A | Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation | April 2003 | April 2004 |
| NCT00075348 | Completed | Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome | December 2003 | December 2008 | |
| NCT00075660 | Completed | Phase 2 | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma | May 11, 2004 | September 22, 2008 |
| NCT00077129 | Completed | Phase 2 | Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer | June 1, 2006 | |
| NCT00080873 | Completed | N/A | Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation | April 2004 | January 2011 |
| NCT00082914 | Completed | Phase 2 | Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | March 2004 | July 2006 |
| NCT00085436 | Completed | Phase 2 | DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | December 2003 | October 2009 |
| NCT00087022 | Completed | Phase 3 | Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | July 2004 | October 2012 |
| NCT00088374 | Completed | Phase 2 | 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease | July 2004 | January 2009 |
| NCT00088803 | Completed | DNA Variations in the Gene in Young Patients With Wilms' Tumor | August 2004 | ||
| NCT00093405 | Completed | Phase 2 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer | August 2004 | November 2005 |
| NCT00096525 | Completed | Phase 2 | Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer | July 2004 | |
| NCT00096629 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Kidney Cancer | November 2003 | April 2018 |
| NCT00098943 | Completed | Phase 1 | NGR-TNF in Treating Patients With Advanced Solid Tumors | September 2004 | |
| NCT00100906 | Completed | Phase 2 | Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer | August 2004 | July 2013 |
| NCT00113217 | Completed | Phase 2 | Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma | February 2005 | August 2012 |
| NCT00118326 | Completed | Phase 1/Phase 2 | Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease | August 2003 | May 2007 |
| NCT00193154 | Completed | Phase 2 | OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma | February 2003 | March 2014 |
| NCT00199875 | Completed | Phase 1 | Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 | July 6, 2005 | March 14, 2013 |
| NCT00199888 | Completed | Phase 1 | Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. | June 2005 | May 29, 2009 |
| NCT00262886 | Completed | Phase 2 | Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer | August 2001 | |
| NCT00263107 | Completed | Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. | August 2004 | June 2005 | |
| NCT00276536 | Completed | Phase 1 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma | January 2001 | January 2004 |
| NCT00276614 | Completed | Phase 2 | Bortezomib in Treating Patients With Metastatic Kidney Cancer | April 2006 | July 2009 |
| NCT00276835 | Completed | Early Phase 1 | Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer | November 2005 | January 2014 |
| NCT00278174 | Completed | Phase 2 | Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer | February 2005 | April 2007 |
| NCT00278369 | Completed | Early Phase 1 | Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer | April 2005 | September 2010 |
| NCT00301847 | Completed | Phase 2 | Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain | November 2005 | |
| NCT00303732 | Completed | Phase 1 | Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors | December 2004 | August 2012 |
| NCT00303940 | Completed | Phase 1 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | December 2005 | February 2010 |
| NCT00310115 | Completed | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | April 2002 | August 2016 | |
| NCT00316901 | Completed | Phase 2 | Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | April 2006 | December 2007 |
| NCT00323739 | Completed | Phase 2 | Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma | May 2006 | March 2011 |
| NCT00331409 | Completed | Phase 2 | Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer | January 2006 | January 2010 |
| NCT00340457 | Completed | Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States | November 16, 2001 | January 1, 2016 | |
| NCT00365287 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | June 2000 | December 2005 |
| NCT00365508 | Completed | Phase 4 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | February 2006 | August 2009 |
| NCT00365768 | Completed | Phase 2 | Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors | October 2004 | June 2012 |
| NCT00369564 | Completed | Phase 3 | Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer | May 2007 | November 2012 |
| NCT00376987 | Completed | Phase 2 | Zinc Supplements in Lowering Cadmium Levels in Smokers | December 2003 | June 2015 |
| NCT00392821 | Completed | Phase 1/Phase 2 | Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer | December 2006 | October 2013 |
| NCT00401128 | Completed | Phase 2 | Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer | May 2004 | February 2007 |
| NCT00403169 | Completed | Phase 2 | Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer | August 2004 | May 2009 |
| NCT00405366 | Completed | Early Phase 1 | Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer | November 2006 | July 2015 |
| NCT00416429 | Completed | Phase 3 | Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer | February 2005 | |
| NCT00416871 | Completed | Phase 3 | Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer | February 2006 | |
| NCT00421512 | Completed | Phase 1 | A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients | March 2006 | May 2008 |
| NCT00422344 | Completed | Phase 1 | A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma | October 2006 | February 2010 |
| NCT00425386 | Completed | Phase 2 | Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer | August 2006 | March 2014 |
| NCT00436410 | Completed | Early Phase 1 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | December 2006 | August 2009 |
| NCT00455975 | Completed | Phase 2 | High-dose Bevacizumab in Advanced Renal Carcinoma Patients | February 2007 | September 2013 |
| NCT00458484 | Completed | N/A | Radiosurgery in Treating Patients With Kidney Tumors | February 20, 2007 | September 12, 2019 |
| NCT00459875 | Completed | Phase 2 | Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer | March 2007 | November 2010 |
| NCT00459979 | Completed | Phase 2 | Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery | March 2007 | September 2013 |
| NCT00462982 | Completed | Phase 2 | Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma | March 2007 | August 2008 |
| NCT00465179 | Completed | Phase 2 | Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer | March 2007 | March 2015 |
| NCT00471432 | Completed | Phase 1 | OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | April 4, 2003 | December 21, 2009 |
| NCT00490698 | Completed | Phase 2 | Zoledronate With Atorvastatin in Renal Cell Carcinoma | October 2006 | January 2012 |
| NCT00492258 | Completed | Phase 3 | Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer | June 2007 | December 2012 |
| NCT00496587 | Completed | Phase 2 | Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma | July 2007 | May 2016 |
| NCT00498966 | Completed | Phase 2 | Ph II Study of Perifosine for Patients With Carcinoma of the Kidney | July 2007 | October 2011 |
| NCT00505310 | Completed | N/A | Biobehavioral Effects of Emotional Expression in Cancer | August 21, 2002 | August 10, 2022 |
| NCT00514215 | Completed | Phase 2 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | January 2006 | March 2010 |
| NCT00534001 | Completed | Phase 2 | Bupropion in Helping Adults Stop Smoking | January 2006 | July 2015 |
| NCT00541008 | Completed | Phase 2 | Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer | September 5, 2007 | April 2013 |
| NCT00588913 | Completed | Phase 1/Phase 2 | Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases | January 2006 | August 2009 |
| NCT00606632 | Completed | Phase 3 | Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody | March 2008 | December 2009 |
| NCT00617799 | Completed | Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma | October 2, 2007 | April 16, 2010 | |
| NCT00620295 | Completed | Phase 1 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | March 2007 | October 2009 |
| NCT00622674 | Completed | Phase 1 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | November 2005 | February 2010 |
| NCT00656734 | Completed | Phase 1 | Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. | April 2008 | June 2010 |
| NCT00659568 | Completed | Phase 1 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | March 2008 | August 2010 |
| NCT00666978 | Completed | Phase 4 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | December 2007 | June 2010 |
| NCT00671411 | Completed | Phase 1 | Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast | March 2008 | November 2011 |
| NCT00743236 | Completed | N/A | Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer | August 2008 | June 2009 |
| NCT00782275 | Completed | Phase 2 | Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma | April 2009 | May 2015 |
| NCT00787761 | Completed | Phase 2 | Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer | April 2007 | May 2012 |
| NCT00790569 | Completed | N/A | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | September 2008 | October 2012 |
| NCT00806650 | Completed | Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer | July 2008 | November 15, 2017 | |
| NCT00814021 | Completed | Phase 2 | Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain | April 2009 | March 2011 |
| NCT00849186 | Completed | N/A | Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer | August 2007 | April 2010 |
| NCT00853021 | Completed | Phase 2 | Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney | December 2005 | October 2009 |
| NCT00854620 | Completed | Phase 2 | Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer | December 2007 | January 2011 |
| NCT00866320 | Completed | Phase 2 | Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab | February 2006 | December 2009 |
| NCT00896454 | Completed | Phase 2 | Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | November 16, 2009 | August 21, 2013 |
| NCT00900042 | Completed | SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer | July 1993 | January 2003 | |
| NCT00900276 | Completed | Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | June 2006 | April 2011 | |
| NCT00900536 | Completed | DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | July 2007 | June 2012 | |
| NCT00943839 | Completed | N/A | Sunitinib Malate in Treating Patients With Kidney Cancer | February 2009 | December 2014 |
| NCT00957424 | Completed | N/A | Acceptability of Less Harmful Alternatives to Cigarettes | June 2009 | November 2011 |
| NCT00967577 | Completed | Phase 1 | 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors | July 2009 | December 31, 2021 |
| NCT01004783 | Completed | Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors | October 2009 | November 2010 | |
| NCT01024205 | Completed | Phase 2 | Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer | August 2007 | May 2012 |
| NCT01048892 | Completed | Phase 1 | Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | September 2009 | |
| NCT01122615 | Completed | Phase 1 | Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) | May 2010 | July 2014 |
| NCT01164228 | Completed | Phase 2 | Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery | September 17, 2010 | November 3, 2021 |
| NCT01184326 | Completed | Phase 1 | Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer | January 2011 | March 2017 |
| NCT01263769 | Completed | Phase 2 | Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) | February 2011 | June 5, 2023 |
| NCT01314391 | Completed | Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor | August 2011 | ||
| NCT01353300 | Completed | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | May 2011 | ||
| NCT01392183 | Completed | Phase 2 | Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | October 24, 2012 | September 8, 2019 |
| NCT01497444 | Completed | Phase 1 | Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery | May 2012 | November 1, 2019 |
| NCT01542333 | Completed | Studying Biomarkers in Samples From Younger Patients With Wilms Tumor | February 2012 | ||
| NCT01544569 | Completed | Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors | March 2012 | ||
| NCT01550393 | Completed | Biomarkers in Urine Samples From Patients With Wilms Tumor | March 2012 | ||
| NCT01553175 | Completed | Studying Gene Expression in Samples From Patients With Rhabdoid Tumors | March 2012 | ||
| NCT01576198 | Completed | Studying Biomarkers in Samples From Younger Patients With Wilms Tumor | April 2012 | ||
| NCT01576211 | Completed | Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor | April 2012 | ||
| NCT01751529 | Completed | Early Phase 1 | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer | May 2013 | November 2015 |
| NCT01775930 | Completed | Phase 2 | Carfilzomib in Refractory Renal Cell Carcinoma (RCC) | October 2013 | January 18, 2019 |
| NCT01894607 | Completed | N/A | Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy | October 2013 | |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT01971905 | Completed | Perfusion Scanning's for Kidney Tumors | February 2014 | January 2018 | |
| NCT02019693 | Completed | Phase 2 | A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer | January 24, 2014 | December 17, 2021 |
| NCT02060370 | Completed | Phase 2 | Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) | August 2014 | January 2, 2019 |
| NCT02118337 | Completed | Phase 1/Phase 2 | A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies | May 19, 2014 | March 17, 2020 |
| NCT02141490 | Completed | Phase 2 | Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | May 15, 2014 | November 20, 2018 |
| NCT02143492 | Completed | Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC | August 2013 | July 2015 | |
| NCT02333279 | Completed | Cancer Development In Organ Transplant Recipients | May 2008 | July 2019 | |
| NCT02431676 | Completed | Phase 2 | Survivorship Promotion In Reducing IGF-1 Trial | May 2015 | December 2018 |
| NCT02687139 | Completed | N/A | Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma | October 2015 | April 2019 |
| NCT02762006 | Completed | Phase 1 | Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma | December 20, 2016 | November 6, 2020 |
| NCT02966509 | Completed | N/A | Engagement of Patients With Advanced Cancer | August 2013 | December 2016 |
| NCT02988219 | Completed | Phase 4 | Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method | June 2010 | December 2016 |
| NCT03065179 | Completed | Phase 2 | SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients | March 1, 2017 | November 17, 2020 |
| NCT03292549 | Completed | RObotic PArtial Nephrectomy National Study | April 2014 | April 2016 | |
| NCT03323021 | Completed | N/A | Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy | May 23, 2017 | February 21, 2019 |
| NCT03334344 | Completed | N/A | Using Virtual Reality (VR) Models for Preoperative Planning | October 24, 2017 | March 18, 2019 |
| NCT03433534 | Completed | Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer | January 29, 2018 | December 21, 2018 | |
| NCT03444766 | Completed | Phase 4 | Study of Nivolumab for Advanced Cancers in India | March 6, 2018 | July 17, 2019 |
| NCT03520231 | Completed | Phase 2 | Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases | September 4, 2018 | December 1, 2020 |
| NCT03568435 | Completed | Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants | February 14, 2018 | December 21, 2020 | |
| NCT03662204 | Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | August 23, 2018 | March 31, 2022 | |
| NCT03663946 | Completed | A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread | September 18, 2018 | May 30, 2020 | |
| NCT03852030 | Completed | N/A | Mind-Body Health in Uro-Oncology: Research Study | July 2012 | July 2016 |
| NCT03887091 | Completed | N/A | Personal Web Page In Clinical Trial Participant Education | July 21, 2014 | May 2019 |
| NCT04021238 | Completed | Phase 2 | Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging | October 7, 2020 | August 5, 2022 |
| NCT04162834 | Completed | Phase 4 | Effect of Papaverine on Renal Artery Blood Flow Volume | November 21, 2019 | April 15, 2021 |
| NCT04180774 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer | January 31, 2001 | December 31, 2018 |
| NCT04222374 | Completed | Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC) | December 10, 2019 | May 1, 2020 | |
| NCT04329767 | Completed | A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy | September 18, 2020 | August 31, 2023 | |
| NCT04342286 | Completed | To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer | May 1, 2020 | February 22, 2021 | |
| NCT04377113 | Completed | Cellular Immunity and Renal Cell Cancer | May 24, 2020 | July 26, 2021 | |
| NCT04388917 | Completed | Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Partial Nephrectomy? | January 1, 2017 | December 31, 2019 | |
| NCT04415697 | Completed | Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas | January 2, 2019 | April 10, 2020 | |
| NCT04430842 | Completed | Phase 1 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | July 20, 2020 | December 22, 2022 |
| NCT04472663 | Completed | Participant Reported Outcomes and Treatment Experiences in Kidney Cancer | July 6, 2020 | December 9, 2020 | |
| NCT04534309 | Completed | N/A | Behavioral Weight Loss Program for Cancer Survivors in Maryland | September 22, 2020 | June 30, 2023 |
| NCT04604158 | Completed | N/A | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | December 2, 2020 | May 17, 2024 |
| NCT04869462 | Completed | DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) | May 27, 2021 | January 29, 2022 | |
| NCT05184725 | Completed | N/A | CARINAE for Stress Relief in Perioperative Care | January 10, 2022 | May 31, 2022 |
| NCT05363072 | Completed | A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. | June 1, 2022 | September 30, 2022 | |
| NCT06214000 | Completed | Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney | December 20, 2021 | June 21, 2022 | |
| NCT06369519 | Completed | Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma | January 1, 2000 | December 31, 2020 | |
| NCT00031564 | Completed | Phase 2 | Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 | May 2000 | June 2012 |
| NCT05487859 | Not yet recruiting | Phase 2 | Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC) | October 5, 2025 | October 6, 2025 |
| NCT06444815 | Not yet recruiting | Phase 1 | A Study of VET3-TGI in Patients With Solid Tumors | August 1, 2024 | December 31, 2027 |
| NCT06138067 | Not yet recruiting | N/A | Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients | July 2024 | December 2026 |
| NCT04670887 | Not yet recruiting | N/A | Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts | March 15, 2021 | January 11, 2036 |
| NCT04005820 | Not yet recruiting | N/A | Impact of Tumour 1q Gain in French Pediatric and Young Adult Patients With Renal Tumours | August 1, 2019 | August 1, 2026 |
| NCT06264479 | Not yet recruiting | Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2 | May 1, 2024 | March 31, 2029 | |
| NCT05184790 | Not yet recruiting | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology | January 31, 2024 | January 31, 2026 | |
| NCT05917106 | Recruiting | Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) | December 26, 2022 | June 2030 | |
| NCT05796973 | Recruiting | Phase 3 | Measuring Oncological Value of Exercise and Statin | March 31, 2023 | December 31, 2027 |
| NCT00026884 | Recruiting | Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease | March 12, 1998 | ||
| NCT05878964 | Recruiting | Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. | May 22, 2023 | September 22, 2024 | |
| NCT03857373 | Recruiting | Renal Cancer Detection Using Convolutional Neural Networks | February 1, 2019 | January 1, 2027 | |
| NCT05899361 | Recruiting | N/A | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | August 30, 2023 | December 25, 2026 |
| NCT03977571 | Recruiting | N/A | Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial | July 6, 2020 | September 1, 2028 |
| NCT03981497 | Recruiting | Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms | February 28, 2018 | December 31, 2030 | |
| NCT05969496 | Recruiting | Phase 2 | Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus | December 4, 2023 | November 2029 |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT05239533 | Recruiting | Phase 2 | Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer | February 16, 2022 | March 2025 |
| NCT06362369 | Recruiting | Phase 1/Phase 2 | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy | May 20, 2024 | December 31, 2028 |
| NCT00033137 | Recruiting | Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer | May 13, 2002 | ||
| NCT05363657 | Recruiting | International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors | January 10, 2022 | December 31, 2028 | |
| NCT05403177 | Recruiting | Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) | June 23, 2022 | October 2026 | |
| NCT05432232 | Recruiting | N/A | The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy | March 23, 2023 | June 2025 |
| NCT02186925 | Recruiting | A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. | August 2014 | August 2025 | |
| NCT00001238 | Recruiting | Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders | December 5, 1990 | ||
| NCT05461027 | Recruiting | Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion | May 1, 2022 | December 31, 2023 | |
| NCT06206707 | Recruiting | N/A | FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis | January 23, 2024 | March 31, 2025 |
| NCT06211790 | Recruiting | Phase 2 | Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma | January 16, 2024 | December 30, 2026 |
| NCT04825834 | Recruiting | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) | March 22, 2021 | May 31, 2026 | |
| NCT05534854 | Recruiting | Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes | October 1, 2022 | August 1, 2025 | |
| NCT04623502 | Recruiting | N/A | An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy | September 30, 2019 | September 30, 2026 |
| NCT04946266 | Recruiting | Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney Cancers | December 1, 2021 | December 2024 | |
| NCT05056077 | Recruiting | N/A | Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) | October 21, 2021 | December 31, 2027 |
| NCT05539677 | Recruiting | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research | September 1998 | December 2030 | |
| NCT05070247 | Recruiting | Phase 1/Phase 2 | A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors | April 14, 2022 | August 11, 2026 |
| NCT05700461 | Recruiting | Phase 1 | Drug Screening Using Novel IMD in Renal Cell Carcinoma | April 24, 2023 | March 2026 |
| NCT02994758 | Recruiting | N/A | Development of Diagnostics and Treatment of Urological Cancers | November 27, 2017 | December 2025 |
| NCT06148220 | Recruiting | N/A | A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors | October 1, 2023 | September 1, 2024 |
| NCT05704985 | Recruiting | Phase 1 | Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | April 3, 2023 | February 2025 |
| NCT05708950 | Recruiting | Phase 1/Phase 2 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | March 3, 2023 | December 31, 2024 |
| NCT03293563 | Recruiting | UroCCR Database: French Research Network for Kidney Cancer | December 2011 | December 2024 | |
| NCT05753839 | Recruiting | N/A | The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial | July 2023 | December 31, 2031 |
| NCT04659343 | Recruiting | TDM for Optimized Outcome in Patients With mRCC. | November 1, 2020 | May 1, 2027 | |
| NCT03414827 | Recruiting | Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma | February 1, 2019 | December 1, 2027 | |
| NCT04393350 | Recruiting | Phase 2 | Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma | June 22, 2020 | August 5, 2024 |
| NCT05805436 | Recruiting | Phase 4 | Preop Laxatives in Robotic Urologic Surgery | June 1, 2023 | March 3, 2025 |
| NCT05820087 | Recruiting | N/A | The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) | January 4, 2024 | December 2029 |
| NCT05119335 | Recruiting | Phase 1/Phase 2 | A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma | October 26, 2021 | September 2026 |
| NCT05842044 | Recruiting | Phase 2 | NSAID Use After Robotic Partial Nephrectomy | September 15, 2023 | September 30, 2025 |
| NCT05861947 | Recruiting | Phase 1 | A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies | August 26, 2023 | June 2025 |
| NCT03571438 | Recruiting | N/A | Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors | October 16, 2017 | September 30, 2024 |
| NCT06041555 | Recruiting | MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy) | January 8, 2024 | January 8, 2029 | |
| NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
| NCT05871008 | Recruiting | N/A | Integrated Actionable Aging Assessment for Cancer Patients Pilot | March 1, 2024 | December 2026 |
| NCT03702309 | Recruiting | Liquid Biopsy Evaluation and Repository Development at Princess Margaret | August 3, 2017 | July 6, 2024 | |
| NCT03786796 | Recruiting | Phase 2 | Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations | June 3, 2019 | March 2026 |
| NCT03804320 | Recruiting | N/A | Protocol Active Surveillance Small Renal Masses (SRMs) | April 29, 2015 | December 11, 2028 |
| NCT03844399 | Recruiting | (3D) Ultrasound Imaging Liver and Kidney | October 3, 2020 | September 2024 | |
| NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
| NCT06278506 | Recruiting | N/A | Resection or Ablation of Small Kidney Tumors | January 31, 2024 | December 2037 |
| NCT04120805 | Recruiting | N/A | Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy | January 1, 2016 | March 1, 2026 |
| NCT04146064 | Recruiting | Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response | February 24, 2020 | May 2024 | |
| NCT05935748 | Recruiting | Phase 2 | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) | July 28, 2023 | September 2026 |
| NCT00050752 | Recruiting | Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer | February 24, 2003 | ||
| NCT05946993 | Recruiting | N/A | Linking In With Advice and Supports for Men Impacted by Metastatic Cancer | May 8, 2023 | April 2025 |
| NCT06016075 | Recruiting | N/A | Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques | January 1, 2023 | January 1, 2026 |
| NCT04322955 | Recruiting | Phase 2 | CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition | June 22, 2020 | February 2027 |
| NCT05961111 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | June 24, 2023 | June 2026 |
| NCT05231655 | Recruiting | Ex VIvo DEtermiNed Cancer Therapy | July 7, 2021 | January 2027 | |
| NCT03134027 | Suspended | Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers | October 19, 2017 | November 2024 | |
| NCT00090870 | Terminated | Phase 2 | PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer | April 2002 | March 2010 |
| NCT00727532 | Terminated | N/A | Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | July 2008 | September 2013 |
| NCT03623490 | Terminated | N/A | Optimizing the Management of Patients With Oral Therapy | May 22, 2018 | May 11, 2021 |
| NCT00747305 | Terminated | Phase 1 | Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery | October 2008 | July 2014 |
| NCT02669914 | Terminated | Phase 2 | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | September 12, 2016 | January 11, 2018 |
| NCT00002947 | Terminated | Phase 1 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | October 1996 | August 2004 |
| NCT04085237 | Terminated | N/A | ESP Block for Laparoscopic Nephrectomy Surgeries | January 4, 2020 | October 16, 2023 |
| NCT01888042 | Terminated | Phase 2 | Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer | July 2011 | July 2014 |
| NCT00788125 | Terminated | Phase 1/Phase 2 | Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors | September 3, 2008 | July 30, 2022 |
| NCT00303719 | Terminated | Phase 2 | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | March 26, 2002 | May 8, 2019 |
| NCT00923390 | Terminated | Phase 1 | Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor | March 2, 2009 | August 24, 2012 |
| NCT00589550 | Terminated | Phase 1 | PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer | February 2008 | January 2009 |
| NCT00831480 | Terminated | Phase 2 | Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal | April 2011 | December 2014 |
| NCT00623077 | Terminated | Phase 1 | MT2004-30: Tomotherapy for Solid Tumors | August 2005 | October 2016 |
| NCT01012362 | Terminated | Phase 1 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | December 2009 | February 2013 |
| NCT00853125 | Terminated | Phase 2 | Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | February 2009 | February 22, 2014 |
| NCT00582790 | Terminated | Phase 2 | Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer | August 2003 | September 2008 |
| NCT00003926 | Terminated | Phase 1 | Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | November 1998 | August 2003 |
| NCT00704938 | Terminated | Phase 2 | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer | June 2008 | August 2009 |
| NCT00323791 | Terminated | Phase 2 | Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer | April 2006 | August 2007 |
| NCT00896467 | Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | September 2007 | November 2010 | |
| NCT00899860 | Terminated | Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer | September 2003 | June 2012 | |
| NCT01068470 | Terminated | Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy | November 2009 | March 2012 | |
| NCT03652298 | Terminated | Phase 2 | Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners | July 25, 2018 | August 27, 2019 |
| NCT00492440 | Terminated | Phase 1 | Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | May 2007 | December 2010 |
| NCT00014131 | Terminated | Phase 1 | Vaccine Therapy in Treating Patients With Kidney Cancer | November 2001 | December 2009 |
| NCT00540969 | Terminated | Phase 3 | Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases | February 2008 | January 2010 |
| NCT00126178 | Terminated | Phase 3 | Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer | May 2005 | March 2006 |
| NCT00176501 | Terminated | Phase 2 | Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | August 2004 | August 2008 |
| NCT00496756 | Terminated | Phase 2 | Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer | March 1, 2007 | April 25, 2014 |
| NCT03824808 | Terminated | Phase 4 | Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery | February 26, 2019 | March 26, 2020 |
| NCT00550654 | Terminated | Phase 2 | Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | October 2007 | May 2010 |
| NCT00243009 | Terminated | Phase 2 | Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery | June 2005 | April 2006 |
| NCT01264341 | Terminated | Phase 2 | Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma | December 2010 | July 2015 |
| NCT00089102 | Terminated | Phase 2 | Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer | September 2003 | July 2009 |
| NCT01185366 | Terminated | Phase 2 | Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma | August 2010 | September 9, 2019 |
| NCT00467077 | Terminated | Phase 2 | Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer | September 2004 | March 2011 |
| NCT00601926 | Terminated | Phase 2 | Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer | February 2008 | May 2013 |
| NCT02511275 | Terminated | N/A | Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique | February 3, 2015 | March 30, 2015 |
| NCT00289146 | Terminated | Comparison of Immune Response Following Surgical Management of Renal Tumors | November 2005 | August 2006 | |
| NCT00089778 | Terminated | Phase 2 | Vaccine Treatment of Kidney Cancer | September 10, 2004 | August 5, 2008 |
| NCT01486550 | Terminated | Phase 4 | Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy | December 2011 | September 2014 |
| NCT00002847 | Unknown status | Phase 2 | Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | September 1995 | |
| NCT00036712 | Unknown status | Phase 2 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | January 2002 | |
| NCT00039169 | Unknown status | Phase 2 | BAY 59-8862 in Treating Patients With Advanced Kidney Cancer | December 2001 | |
| NCT00025103 | Unknown status | Phase 2 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | May 2001 | |
| NCT01230697 | Unknown status | Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM) | June 2010 | September 2011 | |
| NCT00047138 | Unknown status | Phase 3 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | January 2001 | |
| NCT04669613 | Unknown status | N/A | Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell Carcinoma | December 30, 2020 | April 1, 2021 |
| NCT01447199 | Unknown status | The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) | September 1994 | September 30, 2020 | |
| NCT01529658 | Unknown status | N/A | Renal Hypothermia During Partial Nephrectomy | September 2012 | September 2017 |
| NCT00002846 | Unknown status | Phase 2 | Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer | September 1995 | |
| NCT00080977 | Unknown status | Phase 2 | High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 | June 1998 | |
| NCT05109182 | Unknown status | N/A | Virtual 3D Modelling for Improved Surgical Planning of Robotic-assisted Partial Nephrectomy | January 1, 2022 | August 1, 2023 |
| NCT05135832 | Unknown status | N/A | Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma | December 13, 2021 | December 1, 2022 |
| NCT00093522 | Unknown status | Phase 2 | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | August 2004 | |
| NCT02073110 | Unknown status | Optical Biopsy to Improve the Diagnosis of Kidney Cancer | August 2013 | ||
| NCT00024388 | Unknown status | Phase 2 | Chemotherapy in Treating Patients With Metastatic Kidney Cancer | April 2001 | |
| NCT02298608 | Unknown status | Phase 1/Phase 2 | Efficacy and Safety of IRE for RMs | January 2014 | December 2016 |
| NCT02446795 | Unknown status | Phase 1/Phase 2 | Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial | November 2016 | December 2017 |
| NCT00293501 | Unknown status | Phase 1/Phase 2 | Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery | December 2005 | |
| NCT00295997 | Unknown status | N/A | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia | May 2005 | |
| NCT00301990 | Unknown status | Phase 2 | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | September 2005 | |
| NCT02821793 | Unknown status | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer | January 2016 | July 2020 | |
| NCT02828709 | Unknown status | Phase 2 | Safety and Feasibility of IRE for SRMs | July 2016 | July 2019 |
| NCT00024063 | Unknown status | Phase 1 | SU006668 in Treating Patients With Advanced Solid Tumors | ||
| NCT00016042 | Unknown status | Phase 1 | Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer | January 2001 | |
| NCT00349024 | Unknown status | N/A | Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer | July 2005 | |
| NCT03185039 | Unknown status | N/A | Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents | May 29, 2017 | December 13, 2022 |
| NCT00005038 | Unknown status | Phase 2 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | June 1999 | |
| NCT00003804 | Unknown status | Phase 3 | Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor | July 1993 | |
| NCT00003664 | Unknown status | Phase 2 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | October 1998 | |
| NCT00027664 | Unknown status | Phase 2 | Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer | February 2001 | |
| NCT00626509 | Unknown status | Phase 2 | Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer | February 2008 | |
| NCT00003604 | Unknown status | Phase 2 | Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery | October 1997 | |
| NCT00717587 | Unknown status | Phase 2 | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer | June 2008 | |
| NCT00722228 | Unknown status | Phase 1/Phase 2 | Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors | July 2008 | January 2022 |
| NCT00757614 | Unknown status | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | February 2008 | ||
| NCT00002589 | Unknown status | Phase 2 | Lymphocyte Therapy in Treating Patients With Kidney Cancer | July 1994 | |
| NCT00873236 | Unknown status | Phase 2 | MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer | April 2008 | |
| NCT00003181 | Unknown status | Phase 2 | Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | May 1997 | |
| NCT04476641 | Unknown status | Phase 2 | A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors | May 6, 2016 | December 31, 2022 |
| NCT01099423 | Unknown status | Phase 3 | Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer | April 2010 | May 2017 |
| NCT01105364 | Unknown status | N/A | Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer | December 2007 | |
| NCT00030888 | Unknown status | Phase 2 | UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer | December 2002 | |
| NCT00489710 | Withdrawn | Phase 2 | Talabostat in Treating Patients With Metastatic Kidney Cancer | December 2006 | May 30, 2007 |
| NCT00445757 | Withdrawn | Phase 1 | Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors | January 2007 | March 2010 |
| NCT00006126 | Withdrawn | Phase 1 | Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery | September 1999 | April 2001 |
| NCT03035630 | Withdrawn | Phase 2 | Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma | May 23, 2017 | December 2020 |
| NCT00311545 | Withdrawn | Phase 2 | S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer | ||
| NCT05471401 | Withdrawn | N/A | GI Organ Tracking Via Balloon Applicators | April 25, 2023 | May 31, 2025 |
| NCT00025519 | Withdrawn | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer | June 2001 | October 2006 |
| NCT01762592 | Withdrawn | Phase 3 | REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT | December 2017 | December 2019 |
| NCT04260360 | Withdrawn | Phase 1 | Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma | April 2020 | October 2022 |
| NCT00769990 | Withdrawn | Phase 1/Phase 2 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | September 2008 | April 2010 |
| NCT00908739 | Withdrawn | Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer | May 2008 | ||
| NCT00624962 | Withdrawn | N/A | Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors | March 2006 | January 2008 |
- Disase is a (Disease Ontology)
- DOID:3996
- Cross Reference ID (Disease Ontology)
- ICD10CM:C64
- Cross Reference ID (Disease Ontology)
- ICD9CM:189.0
- Cross Reference ID (Disease Ontology)
- MESH:D007680
- Cross Reference ID (Disease Ontology)
- NCI:C120456
- Cross Reference ID (Disease Ontology)
- NCI:C3150
- Cross Reference ID (Disease Ontology)
- NCI:C7548
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126880001
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93849006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0022665
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0494158
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0740457
- Exact Synonym (Disease Ontology)
- malignant neoplasm of kidney except pelvis
- Exact Synonym (Disease Ontology)
- malignant tumour of kidney
- Exact Synonym (Disease Ontology)
- renal cancer